Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant SurgeDavid T. Huang, Christopher Seymour, Mark Schmidhofer et al.|JAMA Network Open|2022Cited by 54
Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19Erin K McCreary, Kevin E. Kip, J Ryan Bariola et al.|JAMA Network Open|2022Cited by 36
The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trialErin K McCreary, David T. Huang, J Ryan Bariola et al.|Contemporary Clinical Trials|2022Cited by 26
Association of subcutaneous or intravenous route of administration of casirivimab and imdevimab monoclonal antibodies with clinical outcomes in COVID-19Erin K McCreary, Kevin E. Kip, J Ryan Bariola et al.|medRxiv|2021Cited by 6
A Prospective Cohort Protocol for the Remnant Investigation in Sepsis StudyChristopher Seymour, Octavia M. Peck Palmer, Kelly Urbanek et al.|Critical Care Explorations|2023Cited by 2